Yunfeng Chen Selected Research

Yunfeng Chen Research Topics

Disease

6	Neoplasms (Cancer) 09/2020 - 06/2014
4	Thrombosis (Thrombus) 10/2022 - 01/2018
3	Hemorrhage 10/2022 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2018
3	Infections 01/2022 - 01/2017
2	Inflammation (Inflammations) 01/2022 - 01/2018
2	Tuberculosis (Tuberculoses) 09/2021 - 01/2017
2	Wounds and Injuries (Trauma) 12/2020 - 04/2014
2	Vascular System Injuries 10/2018 - 09/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022
1	Reperfusion Injury 10/2022
1	Heart Failure 10/2022
1	Hyperthermia 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Pathologic Processes 01/2021
1	Osteonecrosis (Kienbock's Disease) 07/2019
1	Carotid Artery Thrombosis 10/2018
1	Joint Dislocations 06/2018
1	Stroke (Strokes) 01/2018
1	Myocardial Infarction 01/2018
1	Tissue Adhesions 10/2017
1	Glomerulonephritis 10/2017
1	Nephritis 10/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Lymph Node Tuberculosis (Scrofula) 01/2017
1	Photophobia (Light Sensitivity) 02/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2015
1	Melanoma (Melanoma, Malignant) 09/2014
1	Pulmonary Embolism 04/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 04/2014
1	Bone Fractures (Bone Fracture) 04/2014
1	Shoulder Fractures 12/2010

Drug/Important Bio-Agent (IBA)

4	IntegrinsIBA 01/2022 - 09/2014
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2022 - 01/2020
3	LigandsIBA 01/2018 - 03/2015
2	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 06/2014
2	Cisplatin (Platino)FDA LinkGeneric 11/2017 - 06/2014
2	PlatinumIBA 11/2017 - 06/2014
2	HydrogelsIBA 10/2017 - 02/2016
1	LectinsIBA 10/2022
1	Apolipoproteins E (ApoE)IBA 10/2022
1	Galectin 3 (LGALS3)IBA 10/2022
1	dectin 1IBA 10/2022
1	molybdenum disulfideIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	CytokinesIBA 09/2021
1	Interleukin-4 (Interleukin 4)IBA 09/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	LipidsIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Staphylococcal Protein A (Protein A)IBA 01/2021
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 01/2021
1	Pharmaceutical PreparationsIBA 12/2020
1	PorphyrinsIBA 12/2020
1	MetalsIBA 11/2020
1	GoldIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 09/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	von Willebrand FactorIBA 10/2018
1	Platelet Membrane GlycoproteinsIBA 10/2018
1	Monoclonal AntibodiesIBA 10/2018
1	RistocetinIBA 10/2018
1	Capsules (Microcapsules)IBA 06/2018
1	Proteinase-Activated ReceptorsIBA 01/2018
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 01/2018
1	Thrombin FDA Link 01/2018
1	Apolipoproteins AIBA 01/2018
1	EnzymesIBA 11/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2017
1	Fc Receptors (Fc Receptor)IBA 10/2017
1	antiglomerular basement membrane antibodyIBA 10/2017
1	bosutinibIBA 10/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2017
1	InterferonsIBA 01/2017
1	Interferon-gamma (Interferon, gamma)IBA 01/2017
1	Immunoconjugates (Immunoconjugate)IBA 02/2016
1	CollagenIBA 09/2015
1	Syndecan-4IBA 09/2014

Therapy/Procedure

3	Therapeutics 01/2022 - 02/2016
1	Immunomodulation 01/2022
1	Aftercare (After-Treatment) 07/2019
1	Vena Cava Filters (Inferior Vena Cava Filter) 04/2014
1	Internal Fixators 12/2010